Matches in Wikidata for { <http://www.wikidata.org/entity/Q80162395> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q80162395 description "article scientifique publié en 2004" @default.
- Q80162395 description "artículu científicu espublizáu en xunu de 2004" @default.
- Q80162395 description "im Juni 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80162395 description "scientific article published on 01 June 2004" @default.
- Q80162395 description "wetenschappelijk artikel" @default.
- Q80162395 description "наукова стаття, опублікована в червні 2004" @default.
- Q80162395 name "Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome" @default.
- Q80162395 name "Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome" @default.
- Q80162395 type Item @default.
- Q80162395 label "Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome" @default.
- Q80162395 label "Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome" @default.
- Q80162395 prefLabel "Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome" @default.
- Q80162395 prefLabel "Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome" @default.
- Q80162395 P1433 Q80162395-B952A955-F9B4-4F59-BB1A-7435D8E726C9 @default.
- Q80162395 P1476 Q80162395-2C2678C4-7CCA-43A6-BCA0-A80A6D2F10A5 @default.
- Q80162395 P2093 Q80162395-22BF7D4E-7419-4175-953F-301321B3C722 @default.
- Q80162395 P2093 Q80162395-B7A82388-B4DC-4E90-87B2-12CE0D428079 @default.
- Q80162395 P2093 Q80162395-D59E36AC-71D9-41ED-A5DE-2D9147F4FF07 @default.
- Q80162395 P304 Q80162395-4799AC8A-348D-4991-AA7F-7BEDA8A5D72F @default.
- Q80162395 P31 Q80162395-C21F9AA8-3D7C-4597-83CA-50D08F2B4C19 @default.
- Q80162395 P356 Q80162395-588DC55D-9E6A-46A8-BD8B-5D864CCDEFEF @default.
- Q80162395 P433 Q80162395-033CC647-ADF3-42E6-8A16-21F3A38F0961 @default.
- Q80162395 P478 Q80162395-EBFE3CAA-A355-42E9-8497-89E644134F61 @default.
- Q80162395 P577 Q80162395-C0875EA9-0ACA-4129-AC0D-EB386E3D54CB @default.
- Q80162395 P698 Q80162395-944307E7-1C7C-4733-8761-69910DE30360 @default.
- Q80162395 P921 Q80162395-110F497F-F032-4FB4-9623-C2C5B95BB023 @default.
- Q80162395 P921 Q80162395-1F3F991F-C78D-4700-8556-426AA765762F @default.
- Q80162395 P356 J.AMJCARD.2004.02.007 @default.
- Q80162395 P698 15178516 @default.
- Q80162395 P1433 Q2208417 @default.
- Q80162395 P1476 "Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome" @default.
- Q80162395 P2093 "August J Troendle" @default.
- Q80162395 P2093 "David G Orloff" @default.
- Q80162395 P2093 "Jonathan L Isaacsohn" @default.
- Q80162395 P304 "49C-52C" @default.
- Q80162395 P31 Q13442814 @default.
- Q80162395 P356 "10.1016/J.AMJCARD.2004.02.007" @default.
- Q80162395 P433 "11A" @default.
- Q80162395 P478 "93" @default.
- Q80162395 P577 "2004-06-01T00:00:00Z" @default.
- Q80162395 P698 "15178516" @default.
- Q80162395 P921 Q657193 @default.
- Q80162395 P921 Q66291209 @default.